ADME Toxicology Testing Market Size, Growth And Segment Forecasts 2014 To 2020: Grand View Research, Inc

ADME testing or ADME/Tox are gaining popularity owing to the advantages attached to it such as cost and time curbing tool in the process of drug development. Pharmacokinetics of drug is studied in ADME testing. Introduction of computer based assays are also expected to provide this market with lucrative growth opportunities over the forecast period. Late stage drug failure, due to differential results in animal models and human body, represents a substantial burden on the drug development system with respect to time and cost. Drug manufactures are hence incorporating ADME/Tox in early developmental phase. Increasing adoption of ADME toxicology testing is expected to be major growth driver in coming six years.

ADME toxicity testing market is bifurcated into in-vivo and in-vitro technologies. In-vivo technologies market was observed to be most mature market in 2013. On the other hand, in-vitro technologies market is expected to have lucrative growth during the forecast period. This lucrative growth is attributed to the increasing ethical concerns over animal usage in clinical trials. Insilico technologies and hepatocyte testing of in-vivo testing are gaining momentum due early ADME toxicology prediction. Use of computer modeling is trending due to associated increase throughput screening.

Access More Details In-Depth @ http://www.grandviewresearch.com/industry-analysis/adme-toxicology-testing-market

Geographically, the market is studied with respect to North America, Europe, Asia Pacific, Latin America and MEA. North America is expected to be most mature market, owing to larger of drug manufacturing organizations base coupled increasing R&D investments related to drug discovery. Asia Pacific is expected to register lucrative growth due increasing trend of research outsourcing in emerging economies of India and China. Prominent industry players of this market are Accelrys, Inc., Life Technologies Corporation, Inc. Beckman Coulter, Inc., Cellartis AB, Molecular Discovery Ltd.,and Optivia Biotechnology, Inc.

 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Information, Visit Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com

Blog Site: http://www.mediafound.org/